Latest News

  • REGULATORY

    12 Mar 2026

    A Weekly Shot That Helps Kids With Dwarfism Grow

  • INNOVATION

    6 Mar 2026

    Novo Nordisk's $2.1B Wager on a World Without Needles

  • PARTNERSHIPS

    3 Mar 2026

    A $950M Play: GSK Bets on Late Stage Promise

  • RESEARCH

    27 Feb 2026

    Can AI Crack the Code on Fibrosis?

AI Unlocks the Secret to Cell Entry

Automated laboratory instrument inside biotech research facility under purple lighting

INNOVATION

25 Feb 2026

1910 unveils PEGASUS™, an AI platform designed to help macrocyclic drugs cross cell membranes and speed early discovery

Biogen logo on exterior sign outside modern office building

INVESTMENT

23 Feb 2026

$305mn Bet on Peptides Signals Shift in Cancer

Parabilis raises funding from RA Capital, Fidelity and Janus to advance intracellular peptide drugs into late-stage trials

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

AI-Designed Peptide Enters Late-Stage Infection Trial

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Injectable treatment pen and packaging used for metabolic therapy

MARKET TRENDS

19 Feb 2026

GLP-1 Makers Test New Routes to Patients

Drugmakers expand cash-pay and digital channels as competition shifts from clinical results to access and demand control

Scientists reviewing peptide research data in pharmaceutical lab

TECHNOLOGY

18 Feb 2026

Europe Boosts Peptide Output As AI Reshapes R&D

Manufacturers expand capacity for GLP-1 drugs while digital tools gain ground in discovery and early development

Peptilogics corporate logo on gradient background

INSIGHTS

16 Feb 2026

Can Peptides Crack the Biofilm Code?

An $88M raise sends Peptilogics into a pivotal trial targeting stubborn prosthetic joint infections 

Cholesterol monitor showing LDL value and downward arrow

RESEARCH

13 Feb 2026

From Daily Pills to One Genetic Fix

An early CRISPR trial cuts LDL in half, hinting at a future where cholesterol is treated once, not daily

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.